297 related articles for article (PubMed ID: 10500570)
1. The early impact of mycophenolate mofetil in combination with steroids and cyclosporine Neoral after renal transplantation: a six-month analysis.
Cubas A; Herrero JC; Morales E; Carreño A; Dominguez-Gil B; Cirujeda A; Praga M; Ortuño T; Hernandez E; Delgado M; Andres A; Morales JM
Transplant Proc; 1999 Sep; 31(6):2265-6. PubMed ID: 10500570
[No Abstract] [Full Text] [Related]
2. Mycophenolate mofetil, cyclosporine, and steroids after renal transplantation: five-year results at a single center.
Herrero JC; Morales E; Dominguez-Gil B; Carreño A; Cubas A; Andres A; Praga M; Ortuño T; Hernandez E; Rodicio JL; Morales JM
Transplant Proc; 1999 Sep; 31(6):2263-4. PubMed ID: 10500569
[No Abstract] [Full Text] [Related]
3. Improved outcome of steroid withdrawal in mycophenolate mofetil-treated primary cadaveric renal transplant recipients.
Kupin W; Venkat KK; Goggins M; Douzdjian V; Escobar F; Mozes M; Abouljoud M
Transplant Proc; 1999; 31(1-2):1131-2. PubMed ID: 10083505
[No Abstract] [Full Text] [Related]
4. Mycophenolate mofetil eliminates the rationale for antilymphocyte induction therapy in nonhaploidentical living-donor kidney transplants.
Shaffer D; Madras PN; Conway P; Davis C; Simpson MA; Monaco AP
Transplant Proc; 1997; 29(1-2):342-3. PubMed ID: 9123031
[No Abstract] [Full Text] [Related]
5. Mycophenolate mofetil/Neoral/steroid vs Neoral/steroid therapy for prophylaxis of acute rejection in renal transplant recipients.
Carmellini M; Vistoli F; Bellini R; Boggi U; Rindi P; Rizzo G; Mosca F
Transplant Proc; 1999; 31(1-2):1162-4. PubMed ID: 10083519
[No Abstract] [Full Text] [Related]
6. Mycophenolate mofetil in living donor renal allograft recipients.
Park K; Moon JI; Kim SI; Kim YS
Transplant Proc; 1999; 31(1-2):1133. PubMed ID: 10083506
[No Abstract] [Full Text] [Related]
7. Tacrolimus/mycophenolate provides superior immunosuppression relative to neoral/mycophenolate in synchronous pancreas-kidney transplantation.
Bruce DS; Woodle ES; Newell KA; Millis JM; Cronin DC; Loss GE; Grewal HP; Siegel CT; Pellar S; Josephson MA; Thistlethwaite JR
Transplant Proc; 1998 Jun; 30(4):1538-40. PubMed ID: 9636625
[No Abstract] [Full Text] [Related]
8. Induction treatment with mycophenolate mofetil, cyclosporine, and low-dose steroids with subsequent early withdrawal in renal transplant patients: results of the Spanish Group. Spanish Group of the CellCept Study.
Puig i Marí JM
Transplant Proc; 1999 Sep; 31(6):2256-8. PubMed ID: 10500566
[No Abstract] [Full Text] [Related]
9. Mycofenolate mofetil-cyclosporine immunosuppression of kidney transplantation recipients with two different corticosteroid doses.
Remport A; Sasvári I; Toronyi E; Borka P; Lázár N; Járay J; Perner F
Transplant Proc; 2001 May; 33(3):2302-3. PubMed ID: 11377537
[No Abstract] [Full Text] [Related]
10. Triple therapy with mycophenolate mofetil, cyclosporine, and prednisone in renal transplantation.
Crespo JF; Górriz JL; Sancho A; Avila A; Alcoy E; Pallardó LM
Transplant Proc; 1999 Sep; 31(6):2261-2. PubMed ID: 10500568
[No Abstract] [Full Text] [Related]
11. Mycophenolate mofetil as maintenance immunosuppression in pediatric renal transplantation.
Ettenger R; Cohen A; Nast C; Moulton L; Marik J; Gales B
Transplant Proc; 1997; 29(1-2):340-1. PubMed ID: 9123030
[No Abstract] [Full Text] [Related]
12. Triple therapy with mycophenolate mofetil versus azathioprine.
Muñiz ML; Amenabar J; Gómez-Ullate P; Urbizu J; Lampreabe I
Transplant Proc; 1999; 31(1-2):1144-6. PubMed ID: 10083512
[No Abstract] [Full Text] [Related]
13. Randomized trial of tacrolimus in combination with mycophenolate mofetil versus cyclosporine with mycophenolate mofetil in cadaveric renal transplant recipients with delayed graft function.
Liu B; Lin ZB; Ming CS; Zhang WJ; Chen ZS; Sha B; Zeng FJ; Chen S
Transplant Proc; 2003 Feb; 35(1):87-8. PubMed ID: 12591319
[No Abstract] [Full Text] [Related]
14. A prospective randomised study of CSA monotherapy versus CSA plus mycophenolate mofetil in cadaveric renal transplant recipients.
Sells RA; Bakran A; Brown MW; Grinyo J; Hammad A; Hyatt D; Owens G
Transplant Proc; 1998 Dec; 30(8):4098. PubMed ID: 9865311
[No Abstract] [Full Text] [Related]
15. Mycophenolate mofetil (Cellcept) in renal transplantation: the European experience. The European Mycophenolate Mofetil Co-operative Study Group.
Carl S; Wiesel M
Transplant Proc; 1997 Nov; 29(7):2932-5. PubMed ID: 9365619
[No Abstract] [Full Text] [Related]
16. The efficacy of mycophenolate mofetil treatment in the prevention of acute renal rejection is related to plasma level of mycophenolic acid.
Kuriata-Kordek M; Boratyńska M; Klinger M; Woźniak M; Urbaniak J; Szyber P; Patrzalek D; Tupka D
Transplant Proc; 2002 Nov; 34(7):2985-7. PubMed ID: 12431678
[No Abstract] [Full Text] [Related]
17. Mycophenolate mofetil conversion or addition in patients with chronic progressive deterioration of renal allograft function.
Altaca G; Berber I; Aydin C; Yigit B; Aydin M; Titiz I
Transplant Proc; 2001; 33(7-8):3248-9. PubMed ID: 11750391
[No Abstract] [Full Text] [Related]
18. Tacrolimus, mycophenolate mofetil and corticosteroids as primary immunosuppression after renal transplantation at the Hospital 12 de Octubre, Madrid.
Morales JM; Andrés A; Morales E; Herrero JC; Cubas A; Praga M; Hernández E; Ortuño T; Dominguez-Gil B; Carreño A; Delgado M; Manzanares C
Transplant Proc; 1999 Nov; 31(7A):75S-77S. PubMed ID: 10576051
[No Abstract] [Full Text] [Related]
19. Long-term experience with mycofenolate mofetil in the prevention of renal allograft rejection.
Behrend M; Lueck R; Pichlmayr R
Transplant Proc; 1997 Nov; 29(7):2927-9. PubMed ID: 9365617
[No Abstract] [Full Text] [Related]
20. Comparison of two corticosteroid regimens in combination with CellCept and cyclosporine A for prevention of acute allograft rejection: 12 month results of a double-blind, randomized, multi-center study. M 55002 Study Group.
Lebranchu Y
Transplant Proc; 1999; 31(1-2):249-50. PubMed ID: 10083095
[No Abstract] [Full Text] [Related]
[Next] [New Search]